National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 64072 [2022-22908]
Download as PDF
<![CDATA[
64072
Federal Register / Vol. 87, No. 203 / Friday, October 21, 2022 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
[FR Doc. 2022–22908 Filed 10–20–22; 8:45 am]
BILLING CODE 4140–01–P
Dated: October 17, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2022–22836 Filed 10–20–22; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jspears on DSK121TN23PROD with NOTICES
Dated: October 18, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Early-stage Development of
Data Science Technologies for Infectious and
Immune-mediated Diseases (U01 Clinical
Trial Not Allowed); Exploratory Data Science
Methods and Algorithm Development in
Infectious and Immune-mediated Diseases
(R21) Cl.
Date: November 16–17, 2022.
Time: 9:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Vanitha Sundaresa Raman,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20852, 301–761–7949,
vanitha.raman@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
19:08 Oct 20, 2022
Jkt 259001
Submission for OMB Review; 30-Day
Comment Request National Cancer
Institute (NCI) A Generic Submission
for Formative Research, Pretesting and
Customer Satisfaction of NCI’s
Communication and Education
Resources (NCI)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ilene French,
Branch Chief, Office of Communication
and Public Liaison, National Cancer
Institute, 9609 Medical Center Drive,
Maryland 20892 or call non-toll-free
number (240) 276–7787 or email your
request, including your address to:
nciocpl@mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on August 16, 2022, (Vol 87,
No. 157, Page 50340) and allowed 60
days for public comment. One public
comment was received. The purpose of
this notice is to allow an additional 30
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
days for public comment. The National
Cancer Institute (NCI), National
Institutes of Health (NIH), may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid Office of Management
and Budget (OMB) control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, NIH has
submitted to OMB a request for review
and approval of the information
collection listed below.
Proposed Collection: A Generic
Submission for Formative Research,
Pretesting and Customer Satisfaction of
NCI’s Communication and Education
Resources (NCI), 0925–0046, Expiration
Date 11/30/2022, EXTENSION, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: This information collection
request is to approve the Generic
Submission for Formative Research,
Pretesting, and Customer Satisfaction of
NCI’s Communication and Education
Resources (NCI) for three years. As part
of NCI’s mandate from Congress to
disseminate information on cancer
research, detection, prevention, and
treatment, the Institute develops various
messages and materials. Testing these
messages and materials assesses their
potential effectiveness in reaching and
communicating with their intended
audience while they are still in the
developmental stage and can be revised.
The formative research and pretesting
process thus maximize NCI’s limited
dollar resources for information
dissemination and education. NCI also
must ensure the relevance, utility, and
appropriateness of the many
educational programs and products that
the Institute produces. Customer
satisfaction studies help NCI identify
modifications necessary to meet the
needs of NCI’s various target audiences.
Since the previous submission, there
have been six approved sub-studies
with an approved request of 13,473
burden hours over 2.5 years. Approval
is requested for the conduct of multiple
studies annually using such methods as
interviews, focus groups, and various
types of surveys. The content, timing,
and respondents included in each substudy will vary depending on the nature
of the message/material/program being
assessed, the methodology selected, and
the target audiences.
OMB approval is requested for 3
years. There are no costs to respondents
E:\FR\FM\21OCN1.SGM
21OCN1
]]>Agencies
[Federal Register Volume 87, Number 203 (Friday, October 21, 2022)]
[Notices]
[Page 64072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22908]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Early-stage Development of Data
Science Technologies for Infectious and Immune-mediated Diseases
(U01 Clinical Trial Not Allowed); Exploratory Data Science Methods
and Algorithm Development in Infectious and Immune-mediated Diseases
(R21) Cl.
Date: November 16-17, 2022.
Time: 9:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Vanitha Sundaresa Raman, Scientific Review
Officer, Scientific Review Program, National Institute of Allergy
and Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 3G45, Rockville, MD 20852, 301-761-7949,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 18, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-22908 Filed 10-20-22; 8:45 am]
BILLING CODE 4140-01-P
